|
| [July 23, 2008] |
 |
Simulations Plus Subsidiary, Words+, Inc., Releases Major New Product
LANCASTER, Calif. --(Business Wire)-- Words+, Inc., a wholly owned subsidiary of Simulations Plus, Inc. (NASDAQ: SLP), today announced the launch of a major new augmentative communication product called Conversa(TM). Words+, Inc. has been in business since September 1981 as one of the early pioneers in assistive technologies for those who experience various disabilities. Simulations Plus is the leading supplier of simulation and modeling software for preclinical and early clinical pharmaceutical research and development.
Mr. Jeff Dahlen, president of Words+, said: "The new Conversa is based on a state-of-the-art tablet computer with an integrated 12" diagonal touch screen, high quality graphics, and good battery life. We have extended the capabilities of the tablet with our own external package that integrates with the tablet to provide exceptional sound quality and volume in a portable communication device. This product fills a hole in our product line that was created last year when we discontinued our extremely rugged system with a 12" display. That system carried a price tag that was above the Medicare/Medicaid allowable limits. The new Conversa is priced to sell through Medicare and Medicaid funding."
Mr. Gaylon Ponder, national sales manager for Words+, added: "The Conversa is an attractive integration of an existing tablet computer with our own hardware package that neatly blends with the tablet case. Combined with our Say-it! SAM software, this unit provides excellent communication capabilities as well as loud and clear synthetic speech with a variety of voices. Anyone who has tried to carry on a cell phone conversation while in a fast food restaurant knows that communication via an electronic device in some environments requires significant volume and clarity. The new Conversa provides exceptional volume without distortion, and provides a selection of state-of-the-art synthesized voices for adults and children."
Mr. Ponder continued: "Sales of some of our larger systems have been down while our small PDA-based Say-it! SAM systems have been shipping very well. We expect the Conversa to restore the level of large system sales we had and to exceed the former level. Although our previous unit was one of the most rugged units ever made, it was also one of the most expensive, and it did not fit within the Medicare/Medicaid price constraints. So only those who were able to pay for the system outside of these funding agencies were able to obtain them. We believe that the physical attractiveness and superb functionality of the new Conversa, combined with a price point fitting within Medicare/Medicaid guidelines, will result in a nice recovery of the revenues in this part of the augmentative communication market."
About Words+, Inc.
Words+, Inc., was founded in September 1981 out of a need for communication by a family member who had lost her ability to speak from ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease). The company pioneered the application of personal computers to augmentative communication, and has been a technology leader for 27 years in the field. The augmentative communication system used by the world-famous physicist Professor Stephen Hawking has been a Words+ system since 1985. Words+ became a wholly owned subsidiary of Simulations Plus, Inc., in July 1996 when Simulations Plus was incorporated.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development software, which is licensed to and used in the conduct of drug research by pharmaceutical, biotechnology, and drug delivery companies worldwide. The Company has two other businesses, Words+, Inc. and FutureLab(TM), which are based on its proprietary software technologies. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ under the symbol "SLP." For more information, visit our Web site at www.simulations-plus.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 - With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, continued acceptance of our software and hardware products, the general economics of the pharmaceutical and disability industries, our ability to continue to attract and retain highly qualified technical staff, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports as filed with the Securities and Exchange Commission.
[ Back To it.tmcnet.com's Homepage ]
|